These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 28319501)
1. 18F-Fluorocholine PET/CT, Brain MRI, and 5-Aminolevulinic Acid for the Assessment of Tumor Resection in High-Grade Glioma. García Vicente AM; Jiménez Aragón F; Villena Martín M; Jiménez Londoño GA; Borrás Moreno JM Clin Nucl Med; 2017 Jun; 42(6):e300-e303. PubMed ID: 28319501 [TBL] [Abstract][Full Text] [Related]
2. Ischemic Complications After High-Grade Glioma Resection Could Interfere With Residual Tumor Detection With 18F-Fluorocholine PET/CT. García Vicente AM; Rodriguez Muñoz MJ; Pena Pardo FJ; Martinez Madrigal MM; Soriano Castrejón A Clin Nucl Med; 2019 Feb; 44(2):e76-e84. PubMed ID: 30516681 [TBL] [Abstract][Full Text] [Related]
3. Comparison of dual-time point 18F-FDG PET/CT tumor-to-background ratio, intraoperative 5-aminolevulinic acid fluorescence scale, and Ki-67 index in high-grade glioma. Kim YI; Cho KG; Jang SJ Medicine (Baltimore); 2019 Feb; 98(8):e14397. PubMed ID: 30813140 [TBL] [Abstract][Full Text] [Related]
4. FuMeGA Criteria for Visual Assessment of Postoperative 18F-Fluorocholine PET in Patients With Glioma. García Vicente AM; Pena Pardo FJ; Lozano Setien E; Sandoval Valencia H; Villena Martín M Clin Nucl Med; 2020 Jun; 45(6):448-450. PubMed ID: 32349093 [TBL] [Abstract][Full Text] [Related]
5. Comparison of effects of 18F-FDG PET-CT and MRI in identifying and grading gliomas. Song PJ; Lu QY; Li MY; Li X; Shen F J Biol Regul Homeost Agents; 2016; 30(3):833-838. PubMed ID: 27655507 [TBL] [Abstract][Full Text] [Related]
6. Low-Grade Versus High-Grade Glioma… That Is the Question. 18F-Fluorocholine PET in the Detection of Anaplastic Focus. García Vicente AM; Cordero García JM; López Menéndez C; Borrás Moreno JM; Soriano Castrejón A Clin Nucl Med; 2020 May; 45(5):394-397. PubMed ID: 32209884 [TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma. Bette S; Gempt J; Delbridge C; Kirschke JS; Schlegel J; Foerster S; Huber T; Pyka T; Zimmer C; Meyer B; Ringel F World Neurosurg; 2016 May; 89():230-9. PubMed ID: 26855307 [TBL] [Abstract][Full Text] [Related]
8. Promising role of [18F] fluorocholine PET/CT vs [18F] fluorodeoxyglucose PET/CT in primary brain tumors-early experience. Lam WW; Ng DC; Wong WY; Ong SC; Yu SW; See SJ Clin Neurol Neurosurg; 2011 Feb; 113(2):156-61. PubMed ID: 21036467 [TBL] [Abstract][Full Text] [Related]
9. Diverse Behavior in 18F-Fluorocholine PET/CT of Brain Tumors in Patients With Neurofibromatosis Type 1. Pena Pardo FJ; Moreno JMB; Jiménez Aragón F; González García J; García Vicente AM Clin Nucl Med; 2019 Aug; 44(8):e472-e476. PubMed ID: 31274626 [TBL] [Abstract][Full Text] [Related]
10. Impact of [18F]-fluoro-ethyl-tyrosine PET imaging on target definition for radiation therapy of high-grade glioma. Munck Af Rosenschold P; Costa J; Engelholm SA; Lundemann MJ; Law I; Ohlhues L; Engelholm S Neuro Oncol; 2015 May; 17(5):757-63. PubMed ID: 25537018 [TBL] [Abstract][Full Text] [Related]
11. Impact of the combination of 5-aminolevulinic acid-induced fluorescence with intraoperative magnetic resonance imaging-guided surgery for glioma. Tsugu A; Ishizaka H; Mizokami Y; Osada T; Baba T; Yoshiyama M; Nishiyama J; Matsumae M World Neurosurg; 2011; 76(1-2):120-7. PubMed ID: 21839963 [TBL] [Abstract][Full Text] [Related]
12. Association of F18-fluoro-ethyl-tyrosin uptake and 5-aminolevulinic acid-induced fluorescence in gliomas. Stockhammer F; Misch M; Horn P; Koch A; Fonyuy N; Plotkin M Acta Neurochir (Wien); 2009 Nov; 151(11):1377-83. PubMed ID: 19639250 [TBL] [Abstract][Full Text] [Related]
13. Prognostic Potential of Postoperative 18F-Fluorocholine PET/CT in Patients With High-Grade Glioma. Clinical Validation of FuMeGA Postoperative PET Criteria. García Vicente AM; Pena Pardo FJ; Amo-Salas M; Villena Martín M; López Menéndez C; Soriano Castrejón ÁM; Pérez-Beteta J Clin Nucl Med; 2022 Jun; 47(6):480-487. PubMed ID: 35426853 [TBL] [Abstract][Full Text] [Related]
14. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas? Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706 [TBL] [Abstract][Full Text] [Related]
15. ¹⁸F-Fluorocholine PET/CT as a complementary tool in the follow-up of low-grade glioma: diagnostic accuracy and clinical utility. Gómez-Río M; Testart Dardel N; Santiago Chinchilla A; Rodríguez-Fernández A; Olivares Granados G; Luque Caro R; Zurita Herrera M; Chamorro Santos CE; Lardelli-Claret P; Llamas-Elvira JM Eur J Nucl Med Mol Imaging; 2015 May; 42(6):886-95. PubMed ID: 25673054 [TBL] [Abstract][Full Text] [Related]
16. Metabolic approach for tumor delineation in glioma surgery: 3D MR spectroscopy image-guided resection. Zhang J; Zhuang DX; Yao CJ; Lin CP; Wang TL; Qin ZY; Wu JS J Neurosurg; 2016 Jun; 124(6):1585-93. PubMed ID: 26636387 [TBL] [Abstract][Full Text] [Related]
17. Multicentric glioma studied with positron emission tomography: a case report. Sato K; Kameyama M; Ishiwata K; Kayama T; Yoshimoto T; Ito M Surg Neurol; 1994 Jul; 42(1):14-8. PubMed ID: 7940089 [TBL] [Abstract][Full Text] [Related]
18. The usefulness of 18F-fluorocholine PET/CT in the detection of recurrence of central nervous system primary neoplasms. Montes A; Fernández A; Camacho V; de Quintana C; Gallego O; Craven-Bartle J; López D; Molet J; Gómez-Ansón B; Carrió I Rev Esp Med Nucl Imagen Mol; 2017; 36(4):227-232. PubMed ID: 28219644 [TBL] [Abstract][Full Text] [Related]
19. Is It Possible to Establish the Extent of Resection of Glioblastoma With 18F-Fluorocholine PET/CT? García Vicente AM; Perez-Beteta J; Calvo García M; Villena Martín M; Soriano Castrejón A Clin Nucl Med; 2018 Aug; 43(8):e269-e273. PubMed ID: 29894332 [TBL] [Abstract][Full Text] [Related]
20. Illustration of the Added Value of 18F-DOPA PET to Multimodal MRI to Distinguish Low- and High-Grade Gliomas. Louarn N; Kauv P; Capelle L; Mokhtari K; Itti E Clin Nucl Med; 2021 Jul; 46(7):e353-e354. PubMed ID: 33577196 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]